Concepedia

Richard A. Haack

RA

Statistics

Publications

9

Citations

407

H-Index

9

Active since

1982

Affiliations

Abbott Fund(Current)

Richard A. Haack is an author at Abbott Fund specializing in medicinal chemistry, drug discovery, and pharmacology.

ORCID

Publications per year

1982–2018

9

Publications

9

Improved Procedure for the Reduction of N-Acyloxazolidinones

Thomas D. Penning, Stevan W. Djurić, Richard A. Haack et al. · Synthetic Communications · 1990 · 143 citations

, , +1

Structure−Activity Relationship Studies on 1-[2-(4-Phenylphenoxy)ethyl]pyrrolidine (SC-22716), a Potent Inhibitor of Leukotriene A<sub>4</sub> (LTA<sub>4</sub>) Hydrolase

Thomas D. Penning, Nizal S. Chandrakumar, Barbara B. Chen et al. · Journal of Medicinal Chemistry · 2000 · 68 citations · Full text

, , +15

Rhodamine-Derived Fluorescent Dye with Inherent Blinking Behavior for Super-Resolution Imaging

Patrick J. Macdonald, Susan Gayda, Richard A. Haack et al. · Analytical Chemistry · 2018 · 55 citations

, , +16

Kelatorphan and related analogs: potent and selective inhibitors of leukotriene A4 hydrolase

Thomas D. Penning, Leslie J. Askonas, Stevan W. Djurić et al. · Bioorganic & Medicinal Chemistry Letters · 1995 · 35 citations

, , +8

Palladium(0) catalyzed coupling oftrans-1,2-Bis(tri-n-butylstannyl)ethylene with aromatic halides: a convenient Synthesis of substitutedtrans-β-bromostyrenes

Richard A. Haack, Thomas D. Penning, Stevan W. Djurić et al. · Tetrahedron Letters · 1988 · 31 citations

, , +8

1–5 of 9